Truist Lowers its Price Target on Insulet Corporation (PODD) to $360 and Maintains a Buy Rating [Yahoo! Finance]
Insulet Corporation (PODD)
Last insulet corporation earnings: 2/25 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.insulet.com/investor-relations
Company Research
Source: Yahoo! Finance
Insulet Corporation (NASDAQ: PODD is among the 10 High Growth S&P 500 Stocks to Buy Now Truist Lowers its Price Target on Insulet Corporation (PODD) to $360 and Maintains a Buy Rating Truist on February 19, 2026, lowered its price target on Insulet Corporation (NASDAQ:PODD) to $360 from $390 and maintained a Buy rating. The firm said Insulet delivered another strong Q4 beat, supported by broad global strength in Omnipod 5 as the company builds on its first-mover advantage in Type 2 diabetes and leverages direct-to-consumer marketing to drive new patient starts. The same day, Goldman Sachs analyst David Roman reduced the price target to $326 from $363 and kept a Buy rating. David Roman said the U.S. insulin pump market posted strong Q4 growth, with Type 2 adoption adding to continued Type 1 uptake, while the OUS market delivered mid-20s FX-neutral growth. Goldman Sachs added that early-stage Type 2 adoption, conversion from multiple daily injections, and international expansion
Show less
Read more
Impact Snapshot
Event Time:
PODD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PODD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PODD alerts
High impacting Insulet Corporation news events
Weekly update
A roundup of the hottest topics
PODD
News
- Rare Stock Picks In February 2026 - From 12 Discerning Analysts [Seeking Alpha]Seeking Alpha
- Insulet (NASDAQ:PODD) had its price target lowered by analysts at Raymond James Financial, Inc. from $385.00 to $355.00. They now have an "outperform" rating on the stock.MarketBeat
- Insulet (NASDAQ:PODD) had its price target lowered by analysts at Citigroup Inc. from $380.00 to $345.00. They now have a "buy" rating on the stock.MarketBeat
- Insulet Q4 Earnings Review: Strong Performance Meets Sky-High Expectations [Seeking Alpha]Seeking Alpha
- Insulet (NASDAQ:PODD) was given a new $360.00 price target on by analysts at Truist Financial Corporation.MarketBeat
PODD
Earnings
- 2/18/26 - Beat
PODD
Sec Filings
- 3/4/26 - Form 8-K
- 3/3/26 - Form 4
- 3/3/26 - Form 4
- PODD's page on the SEC website